Keizo Sugasawa
Astellas Pharma (Japan)(JP)
Publications by Year
Research Areas
Asymmetric Synthesis and Catalysis, Platelet Disorders and Treatments, Coordination Chemistry and Organometallics, Microtubule and mitosis dynamics, Blood Coagulation and Thrombosis Mechanisms
Most-Cited Works
- → AKR‐501 (YM477) a novel orally‐active thrombopoietin receptor agonist(2008)78 cited
- → Solution structures of a monodentate chiral lithium amide in the presence of lithium halide(1996)68 cited
- → AKR-501 (YM477) in combination with thrombopoietin enhances human megakaryocytopoiesis(2008)61 cited
- → Direct Modulation of Microtubule Stability Contributes to Anthracene General Anesthesia(2013)58 cited
- → Discovery of N -[2-Hydroxy-6-(4-methoxybenzamido)phenyl]-4- (4-methyl-1,4-diazepan-1-yl)benzamide (Darexaban, YM150) as a Potent and Orally Available Factor Xa Inhibitor(2011)35 cited
- → Stereochemistry of enantioselective deprotonation of 4-substituted cyclohexanones by chiral bidentate lithium amides(1997)34 cited
- → Design and Synthesis of (+)-Discodermolide–Paclitaxel Hybrids Leading to Enhanced Biological Activity(2011)33 cited
- → YM477, a Novel Orally-Active Thrombopoietin Receptor Agonist.(2005)16 cited
- → Pharmacological profile of AS1670542, a novel orally-active human thrombopoietin receptor agonist(2010)16 cited
- → Stereoselective Reactions. XXXIV.<SUP>1)</SUP> Enantioselective Deprotonation of Prochiral 4-Substituted Cyclohexanones Using Chiral Bidentate Lithium Amides Having a Bulky Group Instead of a Phenyl Group on the Chiral Carbon(2001)15 cited